Skip to search formSkip to main contentSkip to account menu

RK 28

Known as: RK-28 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
The conditioning effect of RK-28, one of the nitroimidazole nucleoside analogues, in a combined treatment with irradiation… 
1994
1994
The pharmacokinetics of RK-28 [1-(4-hydroxy-2-butenoxy)methyl-2-nitroimidazole], a new hypoxic cell radiosensitizer, was studied… 
1994
1994
The pharmacokinetics of RK-28, a new hypoxic cell radiosensitizer, was studied in rats following its intravenous, intraportal… 
1991
1991
The experimental data previously reported on RK-28, a hypoxic cell sensitizer which is now being tested in a phase I clinical… 
1990
1990
Because of the unsuccessful clinical trials of misonidazole (MISO), many efforts have been made to find a new hypoxic cell… 
Review
1989
Review
1989
There is a world-wide demand for a clinically usable sensitizer for radio resistant hypoxic cells. Since the unsuccessful… 
Highly Cited
1987
Highly Cited
1987
Eleven new hypoxic cell sensitizers representative of those developed in Japan between 1980 and 1985 were evaluated in vitro and…